Existing sleep problems related mainly to disease-related measures, such as pain and reduced function, more so than disease duration
Furthermore, significant changes seen for anxiety, depression, and well-being after therapy dog intervention
Additional benefits include reductions in opioid dosing, emotional distress, and opioid craving
Survivors face increased risk for developing psychological conditions such as depression and anxiety after injury
For patients with opioid use disorder taking buprenorphine-naloxone, it is deemed appropriate to continue three times-daily dosing
Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment
Group-based CBT intervention produced modest, but sustained, reductions in measures of pain, pain-related disability
66 percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20 percent in placebo group
Sleep disturbance in older adults also more common among those living with a partner and urinating at night
Virtual reality intervention also significantly decreases pain among patients undergoing peripheral IV catheter placement